Biotechnology Instrumentation: A Global Strategic Business Report
San Jose, California (PRWEB) March 22, 2012
Follow us on LinkedIn – Though the recent global economic recession affected almost all the industries worldwide, healthcare and biotechnology industries, however, remained the least affected. In fact, some of the major biotech companies were quick enough to rebound from the recessionary impact, and post positive gains. Biotechnology instrumentation sector continues to display healthy growth supported by biotech research expansion in pharmaceutical operations, forensics, agriculture environmental monitoring, and animal husbandry sectors. Growth in the biotechnology instrumentation market could be also attributed to an increase in the number of research projects, involving proteins, genes, and associated biomolecules, following the successful completion of the human genome project. In addition, growth has also been fuelled by an increasing global demand for innovative drugs and therapies, which in turn is fuelling the growth of the drug discovery research.
With the biotech and pharmaceutical companies seeking more sophisticated and meticulous analysis, the market for biotechnology instrumentation is expected to witness robust growth over the next few years. Focus is largely centered upon the development of more advanced, smaller, faster, and highly automated analytical instruments that integrate analytical technologies. Besides, the market is likely to be driven by major technological innovations in almost all the sectors, especially in chip-based products.
The US represents the largest regional market for biotechnology instrumentation globally, followed by the European region, as stated by the new market research report on Biotechnology Instrumentation. The US market is benefiting from the introduction of fast liquid chromatography (LC) technologies. Fast LC systems offer various advantages of superior resolution, high sensitivity, and enhanced throughput, to research laboratories. Besides, research activities in various industries are fostering the demand for electrophoresis instruments in the US. Growth-wise, Asia-Pacific is projected to record the fastest growth over the analysis period, driven by expansion of the Indian and Chinese economies, coupled with a shift into high-technology arenas, such as biotechnology, specialty chemicals, electronics, pharmaceuticals, and steel.
In terms of different instruments, HPLC Equipment and supplies leads the global biotech instrumentation market, driven primarily by the ongoing advancements, such as automation of HPLC systems and hyphenation with mass spectrometry. Demand for liquid chromatography systems is likely to increase globally with growth in proteomics research, as well as improved research activities in various other industries, including food, environmental, life sciences, materials, and chemicals. DNA Sequencers constitutes the second largest and also the second fastest growth biotech instrument type globally. The market for DNA sequencers is expected to witness robust growth, primarily driven by increased competition and technological innovations. Recent system trends indicate a shift from high-throughput DNA Sequencers to medium-throughput systems. However, segment-wise, the fastest growth is forecast to emanate from the Electrophoresis equipment and supplies. As a result of increasing research activity towards development of new drugs, the demand for electrophoresis instruments is expected to remain strong in future.
The biotechnology instrumentation systems market witnessed considerable enhancements in the performance of prevailing technology platforms, and conceptualization of new measurement and instrument configuration systems. The instrument configuration systems are expected to witness the introduction of novel techniques for undertaking biotech research and development. Instances of enhancements in performance of existing technology include rise in throughput rates, minimum run times, incremental analysis on a real time basis, introduction of distinct functions into one device, and the establishment of hybrid instruments extending performance into new application areas.
Major players profiled in the report include Affymetrix Inc., Agilent Technologies Inc., Beckman Coulter, Bio-Rad Laboratories Inc., Dionex Corp., GE HealthCare, Life Technologies Corp., Shimadzu Corp., Thermo Fisher Scientific Inc., PerkinElmer Inc., Hitachi High-Technologies Corp., Waters Corporation, Gilson Inc., among others.
The research report titled “Biotechnology Instrumentation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the biotechnology instrumentation markets, current market trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for biotechnology instrumentation market for the years 2009 through 2017 for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Key segments analyzed include DNA Synthesizers, Protein/Peptide Synthesizers, DNA Sequencers, Protein/Peptide Sequencers, HPLC Equipment & Supplies, and Electrophoresis Equipment & Supplies. Also, a six-year (2003-2008) historic analysis is provided for additional perspective.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/